Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
Market Report I 2024-04-01 I 275 Pages I Allied Market Research
The next generation sequencing market was valued at $ 13 billion in 2023 and is estimated to reach $97.8 billion by 2035, exhibiting a CAGR of 18.3% from 2024 to 2035. Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS, also known as deep sequencing and parallel sequencing, is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.The major factors driving the growth of the NGS market include rise in technological advancements, rise in the number of collaborations & partnerships to promote the use of NGS in hospitals & research centers, and increase in genome mapping programs throughout the world. For instance, in March 2023, Qiagen N.V. N.V. announced the launch of the new QIAseq Platform Partnership program and the first partnership with medical data-analysis provider SOPHiA GENETICSTM that will bring together its QIAseq technology for next-generation sequencing (NGS) with the SOPHiA DDMTM digital analytics platform. Similarly, in June 2021, Labcorp, a global leading life science company, and OmniSeq, a molecular diagnostic of Rosewell Park Comprehensive Cancer Center, together announced the launch of OmniSeq INSIGHT, which is a next generation sequencing platform to advance the precision oncology and improve patient outcome.The next generation sequencing market is segmented into product, application, technology, end user, and region. By product, the market is classified into consumables, platforms, and services. On the basis of application, the market is fragmented into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. On the basis of technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. By end user, the market is divided into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, North Africa, Middle East & Africa).The key players that operate in the next generation sequencing market are Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiend usern N.V., and Thermo Fisher Scientific Inc. The key players have adopted product launch, product development, collaboration, partnership, and product approval as the key strategies to strengthen their foothold in the competitive market.Key Benefits for StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the next generation sequencing market analysis from 2023 to 2035 to identify the prevailing next generation sequencing market opportunities.The market research is offered along with information related to key drivers, restraints, and opportunities.Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.In-depth analysis of the next generation sequencing market segmentation assists to determine the prevailing market opportunities.Major countries in each region are mapped according to their revenue contribution to the global market.Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.The report includes the analysis of the regional as well as global next generation sequencing market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By TECHNOLOGY
- Sequencing by synthesis (SBS)
- Ion semiconductor sequencing (IOS)
- Sequencing by Ligation (SBL)
- Pyrosequencing
- Single-molecule-real-time sequencing (SMRT)
- Others
By END USER
- Academic and clinical research centers
- Pharmaceutical and biotechnology companies
- Hospitals and clinics
- Others
By PRODUCT
- Consumables
- Type
- Sample Preparation Consumables?
- Type
- Other Consumables
- Platforms
- Type
- MiSeq
- Ion Torrent
- SOLiD
- Pacbio Rs II and Sequel System
- Others
- Services
- Type
- Sequencing Services?
- Type
- Data Management Services?
- Type
By APPLICATION
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized medicine
- Agriculture and animal research
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- ILLUMINA INC.
- F. HOFFMANN-LA ROCHE AG
- Qiagen N.V
- abgi group
- PerkinElmer, Inc
- Agilent Technologies, Inc.
- Pacific Biosciences of California
- Thermo Fisher Scientific Inc.
- PRECIGEN INC
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Consumables Next Generation Sequencing Market by Type
4.2.4.1. Sample Preparation Consumables Next Generation Sequencing Market by Type
4.3. Platforms
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Platforms Next Generation Sequencing Market by Type
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Services Next Generation Sequencing Market by Type
4.4.4.1. Sequencing Services Next Generation Sequencing Market by Type
4.4.4.2. Data Management Services Next Generation Sequencing Market by Type
CHAPTER 5: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Biomarkers and Cancer
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Reproductive Health
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Personalized medicine
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Agriculture and animal research
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Others
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
CHAPTER 6: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY
6.1. Overview
6.1.1. Market size and forecast
6.2. Sequencing by synthesis (SBS)
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ion semiconductor sequencing (IOS)
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Sequencing by Ligation (SBL)
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Pyrosequencing
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Single-molecule-real-time sequencing (SMRT)
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Others
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: NEXT GENERATION SEQUENCING MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Academic and clinical research centers
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pharmaceutical and biotechnology companies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Hospitals and clinics
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: NEXT GENERATION SEQUENCING MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by PRODUCT
8.2.3. Market size and forecast, by APPLICATION
8.2.4. Market size and forecast, by TECHNOLOGY
8.2.5. Market size and forecast, by END USER
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by PRODUCT
8.2.6.1.2. Market size and forecast, by APPLICATION
8.2.6.1.3. Market size and forecast, by TECHNOLOGY
8.2.6.1.4. Market size and forecast, by END USER
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by PRODUCT
8.2.6.2.2. Market size and forecast, by APPLICATION
8.2.6.2.3. Market size and forecast, by TECHNOLOGY
8.2.6.2.4. Market size and forecast, by END USER
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by PRODUCT
8.2.6.3.2. Market size and forecast, by APPLICATION
8.2.6.3.3. Market size and forecast, by TECHNOLOGY
8.2.6.3.4. Market size and forecast, by END USER
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by PRODUCT
8.3.3. Market size and forecast, by APPLICATION
8.3.4. Market size and forecast, by TECHNOLOGY
8.3.5. Market size and forecast, by END USER
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by PRODUCT
8.3.6.1.2. Market size and forecast, by APPLICATION
8.3.6.1.3. Market size and forecast, by TECHNOLOGY
8.3.6.1.4. Market size and forecast, by END USER
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by PRODUCT
8.3.6.2.2. Market size and forecast, by APPLICATION
8.3.6.2.3. Market size and forecast, by TECHNOLOGY
8.3.6.2.4. Market size and forecast, by END USER
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by PRODUCT
8.3.6.3.2. Market size and forecast, by APPLICATION
8.3.6.3.3. Market size and forecast, by TECHNOLOGY
8.3.6.3.4. Market size and forecast, by END USER
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by PRODUCT
8.3.6.4.2. Market size and forecast, by APPLICATION
8.3.6.4.3. Market size and forecast, by TECHNOLOGY
8.3.6.4.4. Market size and forecast, by END USER
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by PRODUCT
8.3.6.5.2. Market size and forecast, by APPLICATION
8.3.6.5.3. Market size and forecast, by TECHNOLOGY
8.3.6.5.4. Market size and forecast, by END USER
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by PRODUCT
8.3.6.6.2. Market size and forecast, by APPLICATION
8.3.6.6.3. Market size and forecast, by TECHNOLOGY
8.3.6.6.4. Market size and forecast, by END USER
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by PRODUCT
8.4.3. Market size and forecast, by APPLICATION
8.4.4. Market size and forecast, by TECHNOLOGY
8.4.5. Market size and forecast, by END USER
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by PRODUCT
8.4.6.1.2. Market size and forecast, by APPLICATION
8.4.6.1.3. Market size and forecast, by TECHNOLOGY
8.4.6.1.4. Market size and forecast, by END USER
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by PRODUCT
8.4.6.2.2. Market size and forecast, by APPLICATION
8.4.6.2.3. Market size and forecast, by TECHNOLOGY
8.4.6.2.4. Market size and forecast, by END USER
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by PRODUCT
8.4.6.3.2. Market size and forecast, by APPLICATION
8.4.6.3.3. Market size and forecast, by TECHNOLOGY
8.4.6.3.4. Market size and forecast, by END USER
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by PRODUCT
8.4.6.4.2. Market size and forecast, by APPLICATION
8.4.6.4.3. Market size and forecast, by TECHNOLOGY
8.4.6.4.4. Market size and forecast, by END USER
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by PRODUCT
8.4.6.5.2. Market size and forecast, by APPLICATION
8.4.6.5.3. Market size and forecast, by TECHNOLOGY
8.4.6.5.4. Market size and forecast, by END USER
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by PRODUCT
8.4.6.6.2. Market size and forecast, by APPLICATION
8.4.6.6.3. Market size and forecast, by TECHNOLOGY
8.4.6.6.4. Market size and forecast, by END USER
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by PRODUCT
8.5.3. Market size and forecast, by APPLICATION
8.5.4. Market size and forecast, by TECHNOLOGY
8.5.5. Market size and forecast, by END USER
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by PRODUCT
8.5.6.1.2. Market size and forecast, by APPLICATION
8.5.6.1.3. Market size and forecast, by TECHNOLOGY
8.5.6.1.4. Market size and forecast, by END USER
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by PRODUCT
8.5.6.2.2. Market size and forecast, by APPLICATION
8.5.6.2.3. Market size and forecast, by TECHNOLOGY
8.5.6.2.4. Market size and forecast, by END USER
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by PRODUCT
8.5.6.3.2. Market size and forecast, by APPLICATION
8.5.6.3.3. Market size and forecast, by TECHNOLOGY
8.5.6.3.4. Market size and forecast, by END USER
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by PRODUCT
8.5.6.4.2. Market size and forecast, by APPLICATION
8.5.6.4.3. Market size and forecast, by TECHNOLOGY
8.5.6.4.4. Market size and forecast, by END USER
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. ILLUMINA INC.
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. F. HOFFMANN-LA ROCHE AG
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Qiagen N.V
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. ABGI group
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. PerkinElmer, Inc
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Agilent Technologies, Inc.
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Pacific Biosciences of California
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific Inc.
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. PRECIGEN INC
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 02. NEXT GENERATION SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 2023-2035 ($MILLION)
TABLE 03. GLOBAL CONSUMABLES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 04. GLOBAL SAMPLE PREPARATION CONSUMABLES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 05. NEXT GENERATION SEQUENCING MARKET FOR PLATFORMS, BY REGION, 2023-2035 ($MILLION)
TABLE 06. GLOBAL PLATFORMS NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 07. NEXT GENERATION SEQUENCING MARKET FOR SERVICES, BY REGION, 2023-2035 ($MILLION)
TABLE 08. GLOBAL SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 09. GLOBAL SEQUENCING SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 10. GLOBAL DATA MANAGEMENT SERVICES NEXT GENERATION SEQUENCING MARKET, BY TYPE, 2023-2035 ($MILLION)
TABLE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 12. NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2023-2035 ($MILLION)
TABLE 13. NEXT GENERATION SEQUENCING MARKET FOR BIOMARKERS AND CANCER, BY REGION, 2023-2035 ($MILLION)
TABLE 14. NEXT GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023-2035 ($MILLION)
TABLE 15. NEXT GENERATION SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2023-2035 ($MILLION)
TABLE 16. NEXT GENERATION SEQUENCING MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2023-2035 ($MILLION)
TABLE 17. NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
TABLE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 19. NEXT GENERATION SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS (SBS), BY REGION, 2023-2035 ($MILLION)
TABLE 20. NEXT GENERATION SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING (IOS), BY REGION, 2023-2035 ($MILLION)
TABLE 21. NEXT GENERATION SEQUENCING MARKET FOR SEQUENCING BY LIGATION (SBL), BY REGION, 2023-2035 ($MILLION)
TABLE 22. NEXT GENERATION SEQUENCING MARKET FOR PYROSEQUENCING, BY REGION, 2023-2035 ($MILLION)
TABLE 23. NEXT GENERATION SEQUENCING MARKET FOR SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT), BY REGION, 2023-2035 ($MILLION)
TABLE 24. NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
TABLE 25. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 26. NEXT GENERATION SEQUENCING MARKET FOR ACADEMIC AND CLINICAL RESEARCH CENTERS, BY REGION, 2023-2035 ($MILLION)
TABLE 27. NEXT GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2035 ($MILLION)
TABLE 28. NEXT GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2023-2035 ($MILLION)
TABLE 29. NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY REGION, 2023-2035 ($MILLION)
TABLE 30. NEXT GENERATION SEQUENCING MARKET, BY REGION, 2023-2035 ($MILLION)
TABLE 31. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 32. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 33. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 34. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 35. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2023-2035 ($MILLION)
TABLE 36. U.S. NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 37. U.S. NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 38. U.S. NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 39. U.S. NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 40. CANADA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 41. CANADA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 42. CANADA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 43. CANADA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 44. MEXICO NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 45. MEXICO NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 46. MEXICO NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 47. MEXICO NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 48. EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 49. EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 50. EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 51. EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 52. EUROPE NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2023-2035 ($MILLION)
TABLE 53. GERMANY NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 54. GERMANY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 55. GERMANY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 56. GERMANY NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 57. FRANCE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 58. FRANCE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 59. FRANCE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 60. FRANCE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 61. UK NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 62. UK NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 63. UK NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 64. UK NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 65. ITALY NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 66. ITALY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 67. ITALY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 68. ITALY NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 69. SPAIN NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 70. SPAIN NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 71. SPAIN NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 72. SPAIN NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 73. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 74. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 75. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 76. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 77. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 78. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 79. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 80. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 81. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2023-2035 ($MILLION)
TABLE 82. JAPAN NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 83. JAPAN NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 84. JAPAN NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 85. JAPAN NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 86. CHINA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 87. CHINA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 88. CHINA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 89. CHINA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 90. INDIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 91. INDIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 92. INDIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 93. INDIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 94. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 95. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 96. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 97. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 98. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 99. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 100. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 101. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 102. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 106. LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 107. LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 108. LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 109. LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 110. LAMEA NEXT GENERATION SEQUENCING MARKET, BY COUNTRY, 2023-2035 ($MILLION)
TABLE 111. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 112. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 113. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 114. BRAZIL NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 115. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 116. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 117. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 118. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 119. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 120. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 121. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 122. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 123. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023-2035 ($MILLION)
TABLE 124. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023-2035 ($MILLION)
TABLE 125. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023-2035 ($MILLION)
TABLE 126. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023-2035 ($MILLION)
TABLE 127. ILLUMINA INC.: KEY EXECUTIVES
TABLE 128. ILLUMINA INC.: COMPANY SNAPSHOT
TABLE 129. ILLUMINA INC.: PRODUCT SEGMENTS
TABLE 130. ILLUMINA INC.: SERVICE SEGMENTS
TABLE 131. ILLUMINA INC.: PRODUCT PORTFOLIO
TABLE 132. ILLUMINA INC.: KEY STRATEGIES
TABLE 133. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
TABLE 134. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
TABLE 135. F. HOFFMANN-LA ROCHE AG: PRODUCT SEGMENTS
TABLE 136. F. HOFFMANN-LA ROCHE AG: SERVICE SEGMENTS
TABLE 137. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
TABLE 138. F. HOFFMANN-LA ROCHE AG: KEY STRATEGIES
TABLE 139. QIAGEN N.V: KEY EXECUTIVES
TABLE 140. QIAGEN N.V: COMPANY SNAPSHOT
TABLE 141. QIAGEN N.V: PRODUCT SEGMENTS
TABLE 142. QIAGEN N.V: SERVICE SEGMENTS
TABLE 143. QIAGEN N.V: PRODUCT PORTFOLIO
TABLE 144. QIAGEN N.V: KEY STRATEGIES
TABLE 145. ABGI GROUP: KEY EXECUTIVES
TABLE 146. ABGI GROUP: COMPANY SNAPSHOT
TABLE 147. ABGI GROUP: PRODUCT SEGMENTS
TABLE 148. ABGI GROUP: SERVICE SEGMENTS
TABLE 149. ABGI GROUP: PRODUCT PORTFOLIO
TABLE 150. ABGI GROUP: KEY STRATEGIES
TABLE 151. PERKINELMER, INC: KEY EXECUTIVES
TABLE 152. PERKINELMER, INC: COMPANY SNAPSHOT
TABLE 153. PERKINELMER, INC: PRODUCT SEGMENTS
TABLE 154. PERKINELMER, INC: SERVICE SEGMENTS
TABLE 155. PERKINELMER, INC: PRODUCT PORTFOLIO
TABLE 156. PERKINELMER, INC: KEY STRATEGIES
TABLE 157. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 158. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 159. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 160. AGILENT TECHNOLOGIES, INC.: SERVICE SEGMENTS
TABLE 161. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 162. AGILENT TECHNOLOGIES, INC.: KEY STRATEGIES
TABLE 163. PACIFIC BIOSCIENCES OF CALIFORNIA: KEY EXECUTIVES
TABLE 164. PACIFIC BIOSCIENCES OF CALIFORNIA: COMPANY SNAPSHOT
TABLE 165. PACIFIC BIOSCIENCES OF CALIFORNIA: PRODUCT SEGMENTS
TABLE 166. PACIFIC BIOSCIENCES OF CALIFORNIA: SERVICE SEGMENTS
TABLE 167. PACIFIC BIOSCIENCES OF CALIFORNIA: PRODUCT PORTFOLIO
TABLE 168. PACIFIC BIOSCIENCES OF CALIFORNIA: KEY STRATEGIES
TABLE 169. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
TABLE 170. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 171. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
TABLE 172. THERMO FISHER SCIENTIFIC INC.: SERVICE SEGMENTS
TABLE 173. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 174. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIES
TABLE 175. PRECIGEN INC: KEY EXECUTIVES
TABLE 176. PRECIGEN INC: COMPANY SNAPSHOT
TABLE 177. PRECIGEN INC: PRODUCT SEGMENTS
TABLE 178. PRECIGEN INC: SERVICE SEGMENTS
TABLE 179. PRECIGEN INC: PRODUCT PORTFOLIO
TABLE 180. PRECIGEN INC: KEY STRATEGIES
LIST OF FIGURES
FIGURE 01. NEXT GENERATION SEQUENCING MARKET, 2023-2035
FIGURE 02. SEGMENTATION OF NEXT GENERATION SEQUENCING MARKET,2023-2035
FIGURE 03. TOP IMPACTING FACTORS IN NEXT GENERATION SEQUENCING MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN NEXT GENERATION SEQUENCING MARKET (2024-2035)
FIGURE 05. BARGAINING POWER OF SUPPLIERS
FIGURE 06. BARGAINING POWER OF BUYERS
FIGURE 07. THREAT OF SUBSTITUTION
FIGURE 08. THREAT OF SUBSTITUTION
FIGURE 09. COMPETITIVE RIVALRY
FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. NEXT GENERATION SEQUENCING MARKET, BY PRODUCT, 2023 AND 2035(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY 2023 AND 2035(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PLATFORMS, BY COUNTRY 2023 AND 2035(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SERVICES, BY COUNTRY 2023 AND 2035(%)
FIGURE 15. NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2023 AND 2035(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY 2023 AND 2035(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR BIOMARKERS AND CANCER, BY COUNTRY 2023 AND 2035(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY 2023 AND 2035(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY 2023 AND 2035(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY COUNTRY 2023 AND 2035(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2023 AND 2035(%)
FIGURE 22. NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2023 AND 2035(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SEQUENCING BY SYNTHESIS (SBS), BY COUNTRY 2023 AND 2035(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING (IOS), BY COUNTRY 2023 AND 2035(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SEQUENCING BY LIGATION (SBL), BY COUNTRY 2023 AND 2035(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PYROSEQUENCING, BY COUNTRY 2023 AND 2035(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT), BY COUNTRY 2023 AND 2035(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2023 AND 2035(%)
FIGURE 29. NEXT GENERATION SEQUENCING MARKET, BY END USER, 2023 AND 2035(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR ACADEMIC AND CLINICAL RESEARCH CENTERS, BY COUNTRY 2023 AND 2035(%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2023 AND 2035(%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2023 AND 2035(%)
FIGURE 33. COMPARATIVE SHARE ANALYSIS OF NEXT GENERATION SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2023 AND 2035(%)
FIGURE 34. NEXT GENERATION SEQUENCING MARKET BY REGION, 2023 AND 2035(%)
FIGURE 35. U.S. NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 36. CANADA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 37. MEXICO NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 38. GERMANY NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 39. FRANCE NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 40. UK NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 41. ITALY NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 42. SPAIN NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 43. REST OF EUROPE NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 44. JAPAN NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 45. CHINA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 46. INDIA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 47. AUSTRALIA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 48. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 49. REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 50. BRAZIL NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 51. SAUDI ARABIA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 52. SOUTH AFRICA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 53. REST OF LAMEA NEXT GENERATION SEQUENCING MARKET, 2023-2035 ($MILLION)
FIGURE 54. TOP WINNING STRATEGIES, BY YEAR
FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 57. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 58. COMPETITIVE DASHBOARD
FIGURE 59. COMPETITIVE HEATMAP: NEXT GENERATION SEQUENCING MARKET
FIGURE 60. TOP PLAYER POSITIONING, 2023
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.